van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45(4–5):317–323

Article  PubMed  Google Scholar 

Deshmukh A, Rao KN, Arora RD, Nagarkar NM, Singh A, Shetty OS (2022) Molecular insights into oral malignancy. Indian J Surg Oncol 13(2):267–280

Article  PubMed  Google Scholar 

Pulte D, Brenner H (2010) Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 15(9):994–1001

Article  PubMed  PubMed Central  Google Scholar 

Usman S, Jamal A, Teh MT, Waseem A (2021) Major Molecular Signaling pathways in oral Cancer Associated with Therapeutic Resistance. Front Oral Health 1:603160

Article  PubMed  PubMed Central  Google Scholar 

Wu Q, Liao R, Miao C et al (2024) Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing. Br J Cancer 131(1):77–89

Article  PubMed  CAS  Google Scholar 

Yoshimi A, Abdel-Wahab O (2017) Molecular pathways: understanding and targeting mutant spliceosomal proteins. Clin Cancer Res 23(2):336–341

Article  PubMed  CAS  Google Scholar 

Liu N, Wu Z, Chen A et al (2019) SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26. Cell Death Dis 10(9):667

Article  PubMed  PubMed Central  Google Scholar 

Haugsten EM, Wiedlocha A, Olsnes S, Wesche J (2010) Roles of fibroblast growth factor receptors in carcinogenesis. Mol Cancer Res 8(11):1439–1452

Article  PubMed  CAS  Google Scholar 

Shree Harini K, Ezhilarasan D, Lakshmi T (2022) Novel fibroblast growth factor receptor inhibitors: potential therapeutic approach in oral cancer treatment. Oral Oncol 132:105983

Article  PubMed  CAS  Google Scholar 

Koole K, van Kempen PM, van Bockel LW et al (2015) FGFR4 is a potential predictive biomarker in oral and oropharyngeal squamous cell carcinoma. Pathobiology 82(6):280–289

Article  PubMed  CAS  Google Scholar